The investigators hypothesis is that eltrombopag given to patients with moderate to very severe
Allogeneic hematopoietic stem cell transplantation (aHSCT) can cure patients with a variety of
Mycophenolate mofetil is approved by the U.S. Food and Drug Administration (FDA) to prevent organ rejection in people who have received a kidney, heart, or liver transplant. This medicine comes as a capsule, tablet, or liquid that is taken by mouth. Researchers are currently studying MMF in combination with other medicines for treating
It is in a class of medicines called erythropoiesis-stimulating agents (ESAs).
Scientists believe that